Peptide API Manufacturing Enters a New Era of Innovation and Global Expansion
The global pharmaceutical industry is witnessing a significant transformation driven by advances in Peptide API Manufacturing. As peptide-based therapeutics gain traction in treating chronic diseases such as diabetes, obesity, and cancer, demand for high-quality peptide active pharmaceutical ingredients continues to surge. This trend is reshaping the landscape of Peptide API Manufacturing, pushing contract development and manufacturing organizations (CDMOs) to innovate and scale rapidly to handle this increasing demand.
2026-04-16
Topical Formulation CDMO Gains Momentum as Demand for Advanced Drug Delivery Surges
The global pharmaceutical outsourcing landscape is witnessing rapid transformation, with Topical Formulation CDMO services emerging as a key growth engine. As demand for dermatological and localized therapies continues to rise, Topical Formulation CDMO providers are playing an increasingly strategic role in accelerating drug development and commercialization.
2026-04-09
Date: 28–30 April 2026 Venue: COEX Convention & Exhibition Center, Seoul, South Korea
2026-04-02
Anglonordic Life Science Conference 2026
Date: 23 April 2026 Venue: County Hall, London, UK
2026-04-02
Date: 21–23 April 2026 Venue: Tokyo Big Sight (Tokyo International Exhibition Center), Tokyo, Japan Jiuzhou Booth: 3C-04
2026-04-02
American Association for Cancer Research (AACR)
Date: 17–21 April 2026 Venue: San Diego Convention Center, San Diego, CA, USA
2026-04-02
Date: 21–22 April 2026 Venue: Kongresshalle am Zoo, Leipzig, Germany
2026-04-02
42nd SCI Process Development Symposium 2026
Date: 15–17 April 2026 Venue: Churchill College, University of Cambridge, Cambridge, UK
2026-04-02
Date: 13–16 April 2026 Venue: San Diego Convention Center, San Diego, CA, USA
2026-04-02
Date: 14–16 April 2026 Venue: Paris Expo Porte de Versailles, Paris, France
2026-04-02
Fluorine Chemistry CDMO Accelerates Innovation in Global Pharmaceutical Development
The rapid evolution of the pharmaceutical industry is driving increasing demand for specialized services such as Fluorine Chemistry, a niche yet critical segment supporting the development of advanced drug molecules.
2026-04-02